Register Login
Register to leave comments
  • News bot May 11, 2026, 9:16 p.m.

    🔍 Kumar Neil (Director)

    Company: BridgeBio Pharma, Inc. (BBIO)

    Report Date: 2026-05-07

    Transaction Summary:

    • Total transactions: 13
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares sold: 80,000
    • Total shares held: 234,451

    Detailed Transactions and Holdings:

    • Sold 11,217 shares of Common Stock at $67.495 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 584,469.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 8,333 shares of Common Stock at $68.3775 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 576,136.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
    • Sold 450 shares of Common Stock at $69.0911 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 575,686.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
    • Sold 11,217 shares of Common Stock at $67.4949 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,387,230.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 8,334 shares of Common Stock at $68.3775 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,378,896.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
    • Sold 449 shares of Common Stock at $69.0911 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,378,447.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
    • Sold 13,973 shares of Common Stock at $66.6505 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 561,713.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
    • Sold 5,077 shares of Common Stock at $67.3455 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 556,636.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
    • Sold 950 shares of Common Stock at $68.3477 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 555,686.00 | transaction_form_type: 4 | Footnotes: F1, F8, F3
    • Sold 13,974 shares of Common Stock at $66.6505 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,364,473.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
    • Sold 5,076 shares of Common Stock at $67.3455 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,359,397.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
    • Sold 950 shares of Common Stock at $68.3477 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,358,447.00 | transaction_form_type: 4 | Footnotes: F1, F8, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-07 | Code: H | shares_owned_after: 234,451.00

    Footnotes:

    • F1: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
    • F2: Represents the weighted average sale price of the shares sold from $67.02 to $68.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
    • F3: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
    • F4: Represents the weighted average sale price of the shares sold from $68.02 to $69.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
    • F5: Represents the weighted average sale price of the shares sold from $69.02 to $69.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
    • F6: Represents the weighted average sale price of the shares sold from $66.10 to $67.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
    • F7: Represents the weighted average sale price of the shares sold from $67.10 to $68.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
    • F8: Represents the weighted average sale price of the shares sold from $68.17 to $68.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Search

News categories